Clinical Trials Directory

Trials / Completed

CompletedNCT04019821

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Effects of Super-Bolus on Postprandial Glycemia After High Glycemic Index Meal in Children With Type 1 Diabetes Mellitus- Randomized Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine whether Super-Bolus is more effective in postprandial glycemic control than Normal-Bolus after the high glycemic index (H-GI) meal in children with type 1 diabetes (T1DM) treated with insulin pump (continuous subcutaneous insulin infusion, CSII).

Conditions

Interventions

TypeNameDescription
DRUGInsulin GlulisineA type of bolus insulin will be insulin glulisine if participant used insulin glulisine before entering the trial.
DRUGInsulin AspartA type of bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial.
DRUGInsulin LisproA type of bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial.

Timeline

Start date
2020-01-01
Primary completion
2023-01-01
Completion
2023-04-01
First posted
2019-07-15
Last updated
2023-11-30

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04019821. Inclusion in this directory is not an endorsement.

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal (NCT04019821) · Clinical Trials Directory